US physicians’ intentions regarding impact of human papillomavirus vaccine on cervical cancer screening
Charlene A. Wong(Centers for Disease Control and Prevention), Vicki B. Benard(Centers for Disease Control and Prevention), Zahava Berkowitz(Centers for Disease Control and Prevention), Louise Wideroff(Centers for Disease Control and Prevention), Mona Saraiya(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 7
Related Papers
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
|PsycEXTRA Dataset|2007|1.9k
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
|PubMed|2015|1.1k
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
|JNCI Journal of the National Cancer Institute|2013|997
Human Papillomavirus–Associated Cancers — United States, 2008–2012
|MMWR Morbidity and Mortality Weekly Report|2016|876
Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
|MMWR Morbidity and Mortality Weekly Report|2018|516